AP2009004954A0 - 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer - Google Patents

2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer

Info

Publication number
AP2009004954A0
AP2009004954A0 AP2009004954A AP2009004954A AP2009004954A0 AP 2009004954 A0 AP2009004954 A0 AP 2009004954A0 AP 2009004954 A AP2009004954 A AP 2009004954A AP 2009004954 A AP2009004954 A AP 2009004954A AP 2009004954 A0 AP2009004954 A0 AP 2009004954A0
Authority
AP
ARIPO
Prior art keywords
pyrimidinederivatives
hsp
cer
pyrrolo
dihydro
Prior art date
Application number
AP2009004954A
Other languages
English (en)
Inventor
Luke Raymond Zehnder
Buwen Huang
Michael John Bennett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP2009004954A0 publication Critical patent/AP2009004954A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AP2009004954A 2007-02-06 2008-01-25 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer AP2009004954A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88843307P 2007-02-06 2007-02-06
US2066108P 2008-01-11 2008-01-11
PCT/IB2008/000200 WO2008096218A1 (en) 2007-02-06 2008-01-25 2-amin0-5, 7-dihydr0-6h- pyrrolo [3, 4-d] pyrimidine derivatives as hsp-90 inhibitors for treating cancer

Publications (1)

Publication Number Publication Date
AP2009004954A0 true AP2009004954A0 (en) 2009-08-31

Family

ID=39367692

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004954A AP2009004954A0 (en) 2007-02-06 2008-01-25 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer

Country Status (22)

Country Link
US (1) US20100093696A1 (de)
EP (1) EP2118111B1 (de)
JP (1) JP4523073B2 (de)
KR (1) KR20090116789A (de)
AP (1) AP2009004954A0 (de)
AT (1) ATE502944T1 (de)
AU (1) AU2008212645A1 (de)
BR (1) BRPI0807165A2 (de)
CA (1) CA2677365A1 (de)
CO (1) CO6220971A2 (de)
CR (1) CR10963A (de)
CU (1) CU20090141A7 (de)
DE (1) DE602008005715D1 (de)
DO (1) DOP2009000200A (de)
EA (1) EA200970669A1 (de)
EC (1) ECSP099565A (de)
IL (1) IL200169A0 (de)
MA (1) MA31170B1 (de)
MX (1) MX2009008386A (de)
NI (1) NI200900155A (de)
TN (1) TN2009000329A1 (de)
WO (1) WO2008096218A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2732922A1 (en) * 2008-08-13 2010-02-18 Pfizer Inc. 2-amino pyrimidine compounds as potent hsp-90 inhibitors
GB0907284D0 (en) 2009-04-28 2009-06-10 Queen Mary & Westfield College Compounds for inducing cellular apoptosis
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
AU2010339531A1 (en) 2009-12-30 2012-08-23 Arqule, Inc. Substituted naphthalenyl-pyrimidine compounds
EP2752201A1 (de) 2013-01-04 2014-07-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. C-terminale HSP90-Hemmer zur Behandlung von Hypophysenadenomen
CA2903431C (en) 2013-03-14 2022-12-06 Kalyra Pharmaceuticals, Inc. Bicyclopentane analgesic compounds
EP3080072A4 (de) 2013-12-12 2017-07-19 Kalyra Pharmaceuticals, inc. Bicyclische alkylverbindungen und synthese
JP6741343B2 (ja) 2014-03-07 2020-08-19 リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー プロペラン誘導体および合成
US10336768B2 (en) 2014-06-13 2019-07-02 Yuma Therapeutics, Inc. Pyrimidine compounds and methods using the same
JP6833677B2 (ja) 2014-09-17 2021-02-24 リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー 二環式化合物
US10227029B2 (en) * 2015-08-07 2019-03-12 Kawasaki Jukogyo Kabushiki Kaisha Container holder attached to utility vehicle
AU2018269755B2 (en) 2017-05-15 2022-06-16 Recurium Ip Holdings, Llc Analgesic compounds
WO2020243457A1 (en) * 2019-05-29 2020-12-03 Viogen Biosciences, Llc Compounds and therapeutic uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
NZ520640A (en) 2000-02-15 2005-04-29 Upjohn Co Pyrrole substituted 2-indolinone protein kinase inhibitors
JP4469179B2 (ja) * 2002-01-23 2010-05-26 バイエル ファーマセチカル コーポレーション Ｒｈｏキナーゼ阻害剤としてのピリミジン誘導体
US7312330B2 (en) * 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
JP2008534609A (ja) * 2005-03-30 2008-08-28 コンフォーマ・セラピューティクス・コーポレイション Ｈｓｐ９０阻害剤としてのアルキニルピロロピリミジンおよび関連類似体

Also Published As

Publication number Publication date
TN2009000329A1 (fr) 2010-12-31
WO2008096218A1 (en) 2008-08-14
DE602008005715D1 (de) 2011-05-05
MX2009008386A (es) 2009-10-16
US20100093696A1 (en) 2010-04-15
CO6220971A2 (es) 2010-11-19
NI200900155A (es) 2010-06-30
EA200970669A1 (ru) 2010-02-26
BRPI0807165A2 (pt) 2014-05-06
ATE502944T1 (de) 2011-04-15
CR10963A (es) 2009-08-27
EP2118111A1 (de) 2009-11-18
CA2677365A1 (en) 2008-08-14
EP2118111B1 (de) 2011-03-23
ECSP099565A (es) 2009-09-29
DOP2009000200A (es) 2009-09-15
CU20090141A7 (es) 2011-04-26
IL200169A0 (en) 2010-04-15
MA31170B1 (fr) 2010-02-01
AU2008212645A1 (en) 2008-08-14
JP2010518066A (ja) 2010-05-27
JP4523073B2 (ja) 2010-08-11
KR20090116789A (ko) 2009-11-11

Similar Documents

Publication Publication Date Title
AP2009004954A0 (en) 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer
ZA200809796B (en) Pyrazolo [1,5-A]pyrimidines as CDK inhibitors
HRP20130799T1 (en) 8-heteroaryl-3-alkyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as pi-3 kinases inhibitors
TWI372625B (en) Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
AP2710A (en) Pyrido (2, 3-D) Pyrimidinone compounds and their use as P13 inhibitors
ZA201101090B (en) Pyrido [5,4-d]pyrimidines as cell proliferation inhibitors
GB0814904D0 (en) Search, transfer and bookign tool for multiple reward programs
IL226486A0 (en) Converted pyrazolopyrimidine compounds
SI1893612T1 (sl) Pirolo b piridin derivati kot protein kinazni inhibitorji
PL2004654T3 (pl) Pochodne pirazolopirymidyny do stosowania jako antagonisty kinazy
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
IL194584A0 (en) Imidazo compounds
IL187657A0 (en) Substituted arylpyrazoles for use against parasitites
EP2062004A4 (de) Gitternetz
HK1114380A1 (en) Pyrrolopyrazoles as kinase inhibitors
ZA201004368B (en) Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors
SG10201705968RA (en) Methods for treating dependence
EP1982844A4 (de) Beschichtungstransferwerkzeug
SI2124944T1 (sl) Derivati pirazolo b piridina kot inhibitorji fosfodiesteraze
EP2012791A4 (de) 7,9-dihydro-purin-8-on und analoge daraus als hsp90-hemmer
GB0706632D0 (en) New purine derivatives
AP2008004437A0 (en) Pyrazolo Ä4,3-DÜ pyrimidin-5-yl) derivative used as PDE5 inhibitors
PT2471559E (pt) Método antiviral
ZA200906166B (en) 2-amino-5, 7-dihydro-6H-pyrrolo [3, 4-D] pyrimidine derivatives as HSP-90 inhibitors for treating cancer
HK1129105A1 (en) Pyrazolo